Trigyn Technologies Limited (IN:TRIGYN)
:TRIGYN
Want to see IN:TRIGYN full AI Analyst Report?
Top Page
Trigyn Technologies Limited
(TRIGYN)
Select Model
Select Model
Rating:66Neutral
Price Target:
₹66.00
▼(-14.15% Downside)
Action:ReiteratedDate:04/30/26
The score is primarily supported by solid financial stability (strong balance sheet and improved cash flow) and constructive near-term technicals. It is held back by inconsistent revenue/profitability trends and a very high P/E valuation that increases downside risk if growth or margins do not improve.
Positive Factors
Balance Sheet Health
Trigyn's high equity ratio and conservative leverage reduce refinancing and interest risk, preserving financial flexibility. Over the next several months this stability supports contract bidding, investment in delivery capacity, and resilience to demand shocks without pressuring liquidity.
Negative Factors
Revenue & Profitability Volatility
Inconsistent top-line performance and falling EBIT/net margins indicate persistent pressure on pricing, delivery efficiency or cost control. That volatility undermines long-term margin sustainability, complicates resource planning, and can reduce ability to invest in growth or retain talent.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance Sheet Health
Trigyn's high equity ratio and conservative leverage reduce refinancing and interest risk, preserving financial flexibility. Over the next several months this stability supports contract bidding, investment in delivery capacity, and resilience to demand shocks without pressuring liquidity.
Read all positive factors
Trigyn Technologies Limited (TRIGYN) vs. iShares MSCI India ETF (INDA)
Market Cap
₹1.88B
Dividend YieldN/A
Average Volume (3M)3.83K
Price to Earnings (P/E)74.4
Beta (1Y)1.33
Revenue Growth-2.69%
EPS Growth-86.12%
CountryIN
Employees763
SectorTechnology
Sector Strength88
IndustryInformation Technology Services
Share Statistics
EPS (TTM)0.22
Shares Outstanding30,785,736
10 Day Avg. Volume5,350
30 Day Avg. Volume3,827
Financial Highlights & Ratios
PEG Ratio-0.47
Price to Book (P/B)0.30
Price to Sales (P/S)0.25
P/FCF Ratio4.38
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Trigyn Technologies Limited Business Overview & Revenue Model
Company Description
Trigyn Technologies Limited (TRIGYN) is a global provider of information technology services and solutions, specializing in software development, IT consulting, and staffing services. The company operates across various sectors, including governme...
How the Company Makes Money
Trigyn primarily makes money by delivering IT services under client contracts. Key revenue streams typically include: (1) project-based services where the company designs, builds, and/or maintains software applications and charges clients based on...
Trigyn Technologies Limited Financial Statement Overview
Summary
Income Statement
65
Positive
Balance Sheet
78
Positive
Cash Flow
70
Positive
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.14B | 8.98B | 12.80B | 12.73B | 10.41B | 9.85B |
| Gross Profit | 3.18B | 4.13B | 4.58B | 4.20B | 3.15B | 3.04B |
| EBITDA | 215.41M | 342.52M | 467.44M | 672.79M | 671.35M | 938.87M |
| Net Income | 44.56M | 117.69M | 199.63M | 346.77M | 390.72M | 621.73M |
Balance Sheet | ||||||
| Total Assets | 9.16B | 9.03B | 8.74B | 8.56B | 7.55B | 6.83B |
| Cash, Cash Equivalents and Short-Term Investments | 4.13B | 4.23B | 3.36B | 1.38B | 2.15B | 1.96B |
| Total Debt | 67.42M | 127.60M | 46.98M | 67.83M | 73.56M | 102.27M |
| Total Liabilities | 1.55B | 1.62B | 1.72B | 1.75B | 1.47B | 1.25B |
| Stockholders Equity | 7.62B | 7.41B | 7.01B | 6.81B | 6.08B | 5.58B |
Cash Flow | ||||||
| Free Cash Flow | -620.88M | 513.66M | 1.25B | -576.57M | 292.02M | 771.81M |
| Operating Cash Flow | -612.72M | 514.92M | 1.26B | -520.73M | 449.63M | 802.23M |
| Investing Cash Flow | 114.16M | 157.48M | 682.98M | -628.59M | -314.57M | -14.27M |
| Financing Cash Flow | -12.48M | -34.55M | -37.42M | -28.16M | -56.37M | -45.95M |
Trigyn Technologies Limited Technical Analysis
Neutral
76.88
Price Trends
52.78
Positive
59.46
Negative
69.52
Negative
Market Momentum
1.43
Negative
66.93
Neutral
95.14
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:TRIGYN, the sentiment is Neutral. The current price of 76.88 is above the 20-day moving average (MA) of 48.62, above the 50-day MA of 52.78, and above the 200-day MA of 69.52, indicating a neutral trend. The MACD of 1.43 indicates Negative momentum. The RSI at 66.93 is Neutral, neither overbought nor oversold. The STOCH value of 95.14 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:TRIGYN.
Trigyn Technologies Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | ₹1.82B | -6.20 | ― | 0.49% | 15.16% | 280.16% | |
67 Neutral | ₹2.33B | 28.04 | ― | 0.84% | -14.13% | -53.48% | |
66 Neutral | ₹1.88B | 74.37 | ― | ― | -2.69% | -86.12% | |
66 Neutral | ₹2.11B | 11.60 | ― | ― | 29.99% | 22.77% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
58 Neutral | ₹1.57B | 63.14 | ― | 0.26% | -5.03% | -46.64% | |
55 Neutral | ₹3.68B | 40.24 | ― | ― | -4.24% | ― |
* Technology Sector Average
IN:TRIGYN
Trigyn Technologies Limited
61.12
-13.26
-17.83%
IN:3IINFOLTD
3i Infotech Limited
17.75
-4.41
-19.90%
IN:AARTECH
Aartech Solonics Ltd.
49.52
-5.51
-10.01%
IN:DEVIT
Dev Information Technology Ltd
32.25
-8.69
-21.23%
IN:DRCSYSTEMS
DRC Systems India Limited
14.66
-7.25
-33.09%
IN:INTENTECH
Intense Technologies Limited
98.74
8.44
9.35%
Trigyn Technologies Limited Corporate Events
Trigyn Technologies Chairman Dr. Satyam Cherukuri to Step Down in April 2026
Mar 9, 2026
Trigyn Technologies Limited has announced that Chairman and Non-Executive Director Dr. Satyam Cherukuri has resigned from the board, effective April 7, 2026, citing personal circumstances requiring his full attention. He will also step down from t...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.